Clinical Trials Browser

Phase 1/2 × nedaplatin × Gastrointestinal × Clear all

NCT06010212 2023-08-24

Fruquintinib as First Line Treatment in Patients With Recurrent Esophageal Squamous Cell Carcinoma

Phase 1/2 Not yet recruiting

Gastrointestinal

Esophageal Squamous Cell Carcinoma

NCT05777707 2023-03-21

Neoadjuvant Therapy of PD-1 Blockade Combined With Chemotherapy for Esophageal Carcinoma

Phase 1/2 Unknown

Gastrointestinal

Esophageal Neoplasms